» Articles » PMID: 34336677

A Review of Research on Disparities in the Care of Black and White Patients With Cancer in Detroit

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Aug 2
PMID 34336677
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Racial disparities in cancer incidence and outcomes are well-documented in the US, with Black people having higher incidence rates and worse outcomes than White people. In this review, we present a summary of almost 30 years of research conducted by investigators at the Karmanos Cancer Institute's (KCI's) Population Studies and Disparities Research (PSDR) Program focusing on Black-White disparities in cancer incidence, care, and outcomes. The studies in the review focus on individuals diagnosed with cancer from the Detroit Metropolitan area, but also includes individuals included in national databases. Using an organizational framework of three generations of studies on racial disparities, this review describes racial disparities by primary cancer site, disparities associated with the presence or absence of comorbid medical conditions, disparities in treatment, and disparities in physician-patient communication, all of which contribute to poorer outcomes for Black cancer patients. While socio-demographic and clinical differences account for some of the noted disparities, further work is needed to unravel the influence of systemic effects of racism against Black people, which is argued to be the major contributor to disparate outcomes between Black and White patients with cancer. This review highlights evidence-based strategies that have the potential to help mitigate disparities, improve care for vulnerable populations, and build an equitable healthcare system. Lessons learned can also inform a more equitable response to other health conditions and crises.

Citing Articles

Comparison of the sociodemographic and clinical profiles of cancer patients admitted to a tertiary palliative care unit before and during the COVID-19 pandemic.

Silva Reis B, ODwyer G, Lino V, De Oliveira L, da Costa Rosa K, Sampaio S BMC Palliat Care. 2025; 24(1):27.

PMID: 39881280 PMC: 11776264. DOI: 10.1186/s12904-025-01663-z.


Association Between Race and Comorbid Conditions Among Older Adults with Dementia.

Habibzadeh P, Albrecht J J Clin Med. 2024; 13(21).

PMID: 39518507 PMC: 11546528. DOI: 10.3390/jcm13216368.


Radiation dermatitis in the hairless mouse model mimics human radiation dermatitis.

Lawrence J, Seelig D, Demos-Davies K, Ferreira C, Ren Y, Wang L Sci Rep. 2024; 14(1):24819.

PMID: 39438583 PMC: 11496547. DOI: 10.1038/s41598-024-76021-9.


Effect of chronic disease on racial difference in COVID-19-associated hospitalization among cancer patients.

Wu X, Yu Q, Yi Y, Maniscalco L, Hsieh M, Gruber D J Natl Cancer Inst. 2023; 115(10):1204-1212.

PMID: 37697664 PMC: 10560601. DOI: 10.1093/jnci/djad150.


Health Equity and Antibiotic Prescribing in the United States: A Systematic Scoping Review.

Kim C, Kabbani S, Dube W, Neuhauser M, Tsay S, Hersh A Open Forum Infect Dis. 2023; 10(9):ofad440.

PMID: 37671088 PMC: 10475752. DOI: 10.1093/ofid/ofad440.

References
1.
Penner L, Harper F, Dovidio J, Albrecht T, Hamel L, Senft N . The impact of Black cancer patients' race-related beliefs and attitudes on racially-discordant oncology interactions: A field study. Soc Sci Med. 2017; 191:99-108. PMC: 5706115. DOI: 10.1016/j.socscimed.2017.08.034. View

2.
Henselmans I, de Haes H, Smets E . Enhancing patient participation in oncology consultations: a best evidence synthesis of patient-targeted interventions. Psychooncology. 2012; 22(5):961-77. DOI: 10.1002/pon.3099. View

3.
Schwartz K, Powell I, Underwood 3rd W, George J, Yee C, Banerjee M . Interplay of race, socioeconomic status, and treatment on survival of patients with prostate cancer. Urology. 2009; 74(6):1296-302. PMC: 2791874. DOI: 10.1016/j.urology.2009.02.058. View

4.
Holowatyj A, Cote M, Ruterbusch J, Ghanem K, Schwartz A, Vigneau F . Racial Differences in 21-Gene Recurrence Scores Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer. J Clin Oncol. 2018; 36(7):652-658. PMC: 6366808. DOI: 10.1200/JCO.2017.74.5448. View

5.
Vyas D, Eisenstein L, Jones D . Hidden in Plain Sight - Reconsidering the Use of Race Correction in Clinical Algorithms. N Engl J Med. 2020; 383(9):874-882. DOI: 10.1056/NEJMms2004740. View